• Cancer Research

This year, with your help, we want to raise over $1.3 million for Mater Research—our world-class institute that’s investing in some very promising work in the cancer space.

This money will go towards:

  • funding a range of potentially life-changing projects for those suffering from melanoma, prostate, ovarian and breast cancer, and
  • contributing to global research impact by funding key collaborations with researchers in Queensland, Australia and around the world.

You can check out some of the exciting projects you're helping to fund below. 

A world first at Mater

A world first at Mater

Prostate cancer is not only the most commonly diagnosed cancer in Australian men; it’s also one of the most deadly. And sadly, the number of men diagnosed each year is continuing to rise.

In 2017 it’s predicted that 267 000 men will be living with prostate cancer—more than double the number of diagnoses in 2016.* 

With your help, we want to stop prostate cancer in its tracks!

Because of you, there are already several promising prostate cancer research projects being conducted at Mater Research, including the development of a potential prostate cancer vaccine.

The project, led by Associate Professor Kristin Radford, aims to achieve a longstanding goal in cancer research—to find an ‘anti-tumour vaccine’ that supports a person’s immune system to kill cancer cells and eliminate them throughout the body.

This project has significant long term global impact, and could change the outcomes for future generations.

With the possibility of clinical trials within the next three years, we need your support now more than ever to make sure we don’t lose momentum with this exciting research.  

It’s a long, hard road to fight cancer, but we know you’re up for the challenge.

Are you in?

 

*Source: Australian Institute of Health and Welfare (2015)

Changing the future for women with ovarian cancer

Changing the future for women with ovarian cancer

There’s no sugar coating it, the statistics around ovarian cancer are pretty scary.

For 1400 Australian women the year 2017 will forever be ‘the year I was diagnosed with ovarian cancer’.*

And tragically two-thirds of these women; our mums, sisters, daughters, wives and dear friends, aren’t going to make it … and will eventually die from the disease.

These are pretty alarming stats, and they haven’t changed in 15 years.

It’s time we all put that stake in the ground and say ‘No More’!

The only way to change these statistics, and to give the women we love a brighter future is through investing in research, and that’s where we need your help.

Because of you, the Mater Ovarian Cancer Research Collaborative (MOCRC) are already conducting promising research to increase early diagnoses and raise survival rates. 

With your support, Mater researchers can continue to conduct promising studies like the ‘Genomic changes driving ovarian cancer’ project. This project aims to develop tools to individualise treatment plans for women diagnosed with ovarian cancer, based on their genetics. 

The stark reality is, if these women had been born into a world where Mater’s research projects had already been translated to clinical practice, instead of an unknown and scary future, their treatment and recovery could be very different. 

It’s a long, hard road to fight cancer, but we know you’re up for the challenge.

Are you in?

 

*Source: Australian Institute of Health and Welfare (2015)

Helping the Queensland Melanoma Collaborative

Helping the Queensland Melanoma Collaborative

In Australia, more than 12 960 men and women are diagnosed with melanoma each year.* It’s a statistic that hits particularly close to home for Team Smiddy. In 2006 Mark ‘Sharky’ Smoothy founded Smiling for Smiddy in honour of his good mate Adam Smiddy, a life cut too short by this cruel disease at just 26 years old.

Those who loved Adam have committed to ensuring his legacy in cancer research is a permanent one. They want to ensure there are better outcomes for young men and women for generations to come.

With the support of people like you, a Queensland Melanoma Collaborative has been established, bringing together the State’s leading melanoma clinicians and researchers to find new ways to diagnose, treat, and promote awareness of melanoma. 

But we still need your help to ensure the Collaborative can continue to expand, and ultimately take key melanoma research projects from the ‘lab bench to the patient’s bedside’.

The reality is, if Adam Smiddy had been born into a world where Mater’s research projects had already been translated to clinical practice, instead of a life cut short, his treatment and recovery would have been very different.

He may even still be with us here today. 

It’s a long, hard road to fight cancer, but we know you’re up for the challenge.

Are you in?

 

*Source: Australian Institute of Health and Welfare (2015)

The Mater Foundation is registered as a charity with the Australian Charities and Not-for-profits Commission ABN 96723184640.